A recent study indicates that people who discontinue popular GLP-1 drugs like Mounjaro or Wegovy can put back on shed pounds far faster than those who halt traditional diet and exercise regimens.
Findings released in a major health publication shows that while overweight people can lose substantial amounts of their body weight while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals buying such treatments should be cognizant of the danger of quick rebound weight gain when the medication ends," stated researcher Dr. Susan Jebb.
This pace of recovery suggests a reversion to pre-treatment weight in about 18 months.
Analyzing Treatments
The research, which reviewed dozens of trials involving over 9,000 of participants, contrasted the effects of the injectable medications with older methods.
The team point out that individuals who lose weight through lifestyle changes alone generally see a slower weight regain—approximately 100 grams monthly—post-intervention.
Understanding the Fast Rebound
Nutrition scientists suggest the mode of action of the drugs is key to understanding the heightened weight return.
These medications copy a natural hormone called GLP-1, which controls feelings of fullness.
"Long-term administration of GLP-1 levels several times higher than normal might result in the body to generate a reduced amount of its endogenous hormone, and could diminish responsiveness to its effects," noted Dr. Adam Collins, a dietetics expert.
"Withdrawal of this medication means hunger is unsuppressed, making excessive eating far more likely."
An Ongoing Issue?
Medical guidelines recommend the injections for people with weight-linked health risks, alongside recommended lifestyle changes.
A number of clinicians argue that, given the likelihood of relapse, the treatment is often life-long.
This perspective is reinforced by drug manufacturers, who state that the findings "highlight the persistent nature of obesity," comparing it to managing conditions like diabetes.
User Experiences
Users who have stopped the jabs report a intense resurgence of appetite.
"It was like a trigger that goes on and I was suddenly extremely hungry," described an individual.
This difficulty is compounded if individuals have not established permanent lifestyle or habit modifications during treatment.
Growing Interest
Figures indicate that a significant number of people in the UK have used these injections in the past year, with desire continuing to grow.
- Use is higher among females than men.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than the NHS.
In conclusion, clinicians caution that while the jabs are powerful agents for weight loss, they are not a magic fix and maintained weight loss likely depends on ongoing lifestyle management.
